NOTICE: Labnodes now supports email addresses. If your email changed, please update your profile today.
  1. All aglow about presynaptic receptor regulation of neurotransmitter transporters. Blakely RD, DeFelice LJ (2007) Mol Pharmacol 71(5): 1206-8
    › Primary publication · 17329498 (PubMed)
  2. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. Henry LK, Field JR, Adkins EM, Parnas ML, Vaughan RA, Zou MF, Newman AH, Blakely RD (2006) J Biol Chem 281(4): 2012-23
    › Primary publication · 16272152 (PubMed)
  3. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Zhu CB, Blakely RD, Hewlett WA (2006) Neuropsychopharmacology 31(10): 2121-31
    › Primary publication · 16452991 (PubMed)
  4. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current. Binda F, Lute BJ, Dipace C, Blakely RD, Galli A (2006) Neuropharmacology 50(3): 354-61
    › Primary publication · 16289633 (PubMed)
  5. The high-affinity choline transporter: a critical protein for sustaining cholinergic signaling as revealed in studies of genetically altered mice. Bazalakova MH, Blakely RD (2006) Handb Exp Pharmacol (175): 525-44
    › Primary publication · 16722248 (PubMed)
  6. The Caenorhabditis elegans choline transporter CHO-1 sustains acetylcholine synthesis and motor function in an activity-dependent manner. Matthies DS, Fleming PA, Wilkes DM, Blakely RD (2006) J Neurosci 26(23): 6200-12
    › Primary publication · 16763028 (PubMed)
  7. Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter. Carneiro AM, Blakely RD (2006) J Biol Chem 281(34): 24769-80
    › Primary publication · 16803896 (PubMed) · PMC3875312 (PubMed Central)
  8. Norepinephrine transporter-deficient mice respond to anxiety producing and fearful environments with bradycardia and hypotension. Keller NR, Diedrich A, Appalsamy M, Miller LC, Caron MG, McDonald MP, Shelton RC, Blakely RD, Robertson D (2006) Neuroscience 139(3): 931-46
    › Primary publication · 16515844 (PubMed)
  9. Na+, Cl-, and pH dependence of the human choline transporter (hCHT) in Xenopus oocytes: the proton inactivation hypothesis of hCHT in synaptic vesicles. Iwamoto H, Blakely RD, De Felice LJ (2006) J Neurosci 26(39): 9851-9
    › Primary publication · 17005849 (PubMed)
  10. High affinity inhibitors of the dopamine transporter (DAT): novel biotinylated ligands for conjugation to quantum dots. Tomlinson ID, Mason JN, Blakely RD, Rosenthal SJ (2006) Bioorg Med Chem Lett 16(17): 4664-7
    › Primary publication · 16784853 (PubMed)